Too Much Medicine: controversy over breast cancer screening program in UK
Find out why a group of 15 health experts have written to the Times about the NHS breast cancer screening program, saying women should not be subjected to "fear-mongering".
Lisa Schwartz and Steve Woloshin cited on LitHub essay: “Why I’m giving up on preventative care”
Read this opinion piece about aging and preventative care, which cites work from Too Much Medicine's Steve Woloshin and Lisa Schwartz.
Gary Schwitzer: Patient harm from misleading media
HealthNewsReview.org celebrates its 12th anniversary today, April 17, 2018. Look forward to a new series, "Patient harm from misleading media", which will look at the very real harm that can be…
Paul Glasziou: Incremental Benefits and Harms of New High Blood Pressure Guideline
The recent recommendations from the American College of Cardiology and the American Heart Association (ACC/AHA) to lower the thresholds for defining hypertension and for treating higher-risk patients have been controversial. Changing…
Allen Frances: Many People Taking Antidepressants Discover They Cannot Quit
Read this piece in The New York Times on the proliferation of long-term antidepressant use and the challenges of discontinuation. And you can watch Allen Frances argue that when people face "mild,…
Too Much Medicine: Doctors “keeping drug company cash secret”
Doctors' conflicts of interests are not being reported by NHS hospitals, undermining public trust. Read research in the BMJ Open that sought to document how the NHS records and shares disclosures…
Cork, Ireland
Rachelle Buchbinder: Lancet series on low back pain
Read this three part series on low back pain in The Lancet. Led by Rachelle Buchbinder, these papers address the issues around low back pain and call for worldwide recognition of…
James McCormak: Effectiveness of antidepressants: lots of useful data, many questions remain
Read James McCormack's BMJ editorial on a recent meta-analysis of the effectiveness of antidepressants. What is the clinical relevance of the meta-analysis and how should these findings inform practice?
Too Much Medicine Symposium and Preventing Overdiagnosis Conference: Better Together
The Too Much Medicine Symposium and the Preventing Overdiagnosis Conference have teamed up to bring you an interesting and informative week of speakers on this important topic, against the beautiful…
Too Much Medicine: the CAP Randomized Trial on PSA Screening and Prostate Cancer Mortality
The largest-ever prostate cancer screening trial was published this week in JAMA, and showed that there was no effect of a low-intensity PSA screening test on cancer mortality over 10…